Medicare's Drug Discount Card Program: Beneficiaries' Experience with Choice.
This article describes Medicare beneficiaries' experience with the choice among Medicare drug discount cards and is based primarily on surveys and focus groups with beneficiaries as well as interviews with other stakeholders. Although competition and choice have the potential to reduce cost and enha...
| Publicado en: | Health Care Financing Review Vol. 28; no. 4; pp. 1 - 14 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
HCFA ORDS Publications
Summer 2007
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=510662822&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 510662822 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 01958631 HCF jtl: Health Care Financing Review issn: 01958631 maglogo: N pubinfo: dt: Summer 2007 vid: 28 iid: 4 pid: 187 pub: HCFA ORDS Publications artinfo: ui: 510662822 ppf: 1 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P size: 1MB tig: atl: Medicare's Drug Discount Card Program: Beneficiaries' Experience with Choice. aug: au: Hassol, Andrea Wrobel, Marian V. Doksum, Teresa su: Medicare Part D Medicare Prescription Drug, Improvement, & Modernization Act sug: subj: Medicare Part D Medicare Prescription Drug, Improvement, & Modernization Act keyword: Health discount cards ab: This article describes Medicare beneficiaries' experience with the choice among Medicare drug discount cards and is based primarily on surveys and focus groups with beneficiaries as well as interviews with other stakeholders. Although competition and choice have the potential to reduce cost and enhance quality in the Medicare Program, our findings highlight some of the challenges involved in making choice work in practice. Despite the unique and temporary nature of the drug discount card program, these findings have considerable relevance to the Part D drug benefit and to other Medicare initiatives that rely on choice. Reprinted by permission of the publisher. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|